Immunitrack Overview
- Year Founded
-
2013

- Status
-
Acquired/Merged
- Employees
-
16

- Latest Deal Type
-
M&A
- Investors
-
1
Immunitrack General Information
Description
Developer of an AI-based prediction and assessment platform designed to assist biotech and pharma companies. The company offers contracted research to the pharmaceutical industry predicting how the immune system reacts to different pharmaceuticals, by producing reagents that can be used to examine the immune system's reaction, enabling biotech and pharma companies to produce new biologics and vaccines easily.
Contact Information
Website
www.immunitrack.comCorporate Office
- Lersø Parkallé 42
- 2100 Copenhagen
- Denmark
Corporate Office
- Lersø Parkallé 42
- 2100 Copenhagen
- Denmark
Immunitrack Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
7. Merger/Acquisition | 10-Apr-2023 | Completed | Generating Revenue | |||
6. Accelerator/Incubator | 24-Jun-2020 | Completed | Generating Revenue | |||
5. Grant | 08-Aug-2019 | Completed | Generating Revenue | |||
4. Seed Round | 05-Jun-2018 | Completed | Generating Revenue | |||
3. Accelerator/Incubator | 01-Jan-2017 | Completed | Generating Revenue | |||
2. Accelerator/Incubator | 24-Nov-2016 | Completed | Generating Revenue | |||
1. University Spin-Out | 01-Jan-2013 | Completed | Startup |
Immunitrack Signals
Immunitrack Former Investors (6)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Accelerace | Venture Capital | Minority | ||
Blenheim Capital (Investor) | Venture Capital | Minority | ||
EASME - EU Executive Agency for SMEs | Corporation | Minority | ||
Eurostars | Other | |||
Invest Horizon | Accelerator/Incubator |
Immunitrack FAQs
-
When was Immunitrack founded?
Immunitrack was founded in 2013.
-
Where is Immunitrack headquartered?
Immunitrack is headquartered in Copenhagen, Denmark.
-
What is the size of Immunitrack?
Immunitrack has 16 total employees.
-
What industry is Immunitrack in?
Immunitrack’s primary industry is Discovery Tools (Healthcare).
-
Is Immunitrack a private or public company?
Immunitrack is a Private company.
-
What is Immunitrack’s current revenue?
The current revenue for Immunitrack is
. -
How much funding has Immunitrack raised over time?
Immunitrack has raised $4.12M.
-
Who are Immunitrack’s investors?
Accelerace, Blenheim Capital (Investor), EASME - EU Executive Agency for SMEs, Eurostars, and Invest Horizon are 5 of 6 investors who have invested in Immunitrack.
-
When was Immunitrack acquired?
Immunitrack was acquired on 10-Apr-2023.
-
Who acquired Immunitrack?
Immunitrack was acquired by Eli Lilly.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »